A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions

Diabetes MellitusInsulin Sensitivity

Interventions

DRUG

Retatrutide

Administered SC

DRUG

Semaglutide

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (1)

RECRUITING

Profil Institut für Stoffwechselforschung, Neuss

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY